{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:35:39Z","timestamp":1790818539944,"version":"4.1.0"},"reference-count":36,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG project","doi-asserted-by":"publisher","award":["KU3500\/2-1"],"award-info":[{"award-number":["KU3500\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG project","doi-asserted-by":"publisher","award":["BMBF 02NUK 064A"],"award-info":[{"award-number":["BMBF 02NUK 064A"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG project","doi-asserted-by":"publisher","award":["BMWi ZF4320102CS7"],"award-info":[{"award-number":["BMWi ZF4320102CS7"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Non-small cell lung cancer (NSCLC) is the second most frequently diagnosed tumor worldwide. Despite the clinical progress which has been achieved by multimodal therapies, including radiochemotherapy, and immune checkpoint inhibitor blockade, the overall survival of patients with advanced-stage NSCLC remains poor, with less than 16 months. It is well established that many aggressive tumor entities, including NSCLC, overexpress the major stress-inducible heat shock protein 70 (Hsp70) in the cytosol, present it on the plasma membrane in a tumor-specific manner, and release Hsp70 into circulation. Although high Hsp70 levels are associated with tumor aggressiveness and therapy resistance, membrane-bound Hsp70 can serve as a tumor-specific antigen for Hsp70-primed natural killer (NK) cells, expressing the C-type lectin receptor CD94, which is part of the activator receptor complex CD94\/NKG2C. Therefore, we investigated circulating Hsp70 levels and changes in the composition of peripheral blood lymphocyte subsets as potential biomarkers for the advanced Union for International Cancer Control (UICC) stages in NSCLC. As expected, circulating Hsp70 levels were significantly higher in NSCLC patients compared to the healthy controls, as well as in patients with advanced UICC stages compared to those in UICC stage I. Smoking status did not influence the circulating Hsp70 levels significantly. Concomitantly, the proportions of CD4+ T helper cells were lower compared to the healthy controls and stage I tumor patients, whereas that of CD8+ cytotoxic T cells was progressively higher. The prevalence of CD3\u2212\/CD56+, CD3\u2212\/NKp30, CD3\u2212\/NKp46+, and CD3\u2212\/NKG2D+ NK cells was higher in stage IV\/IIIB of the disease than in stage IIIA but were not statistically different from that in healthy individuals. However, the proportion of NK cells expressing CD94 and the activation\/exhaustion marker CD69 significantly increased in higher tumor stages compared with stage I and the healthy controls. We speculate that although elevated circulating Hsp70 levels might promote the prevalence of CD94+ NK cells in patients with advanced-stage NSCLC, the cytolytic activity of these NK cells also failed to control tumor growth due to insufficient support by pro-inflammatory cytokines from CD4+ T helper cells. This hypothesis is supported by a comparative multiplex cytokine analysis of the blood in lung cancer patients with a low proportion of CD4+ T cells, a high proportion of NK cells, and high Hsp70 levels versus patients with a high proportion of CD4+ T cells exhibiting lower IL-2, IL-4, IL-6, IFN-\u03b3, granzyme B levels.<\/jats:p>","DOI":"10.3390\/cancers14225701","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T04:13:36Z","timestamp":1669004016000},"page":"5701","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Elevated Levels of Circulating Hsp70 and an Increased Prevalence of CD94+\/CD69+ NK Cells Is Predictive for Advanced Stage Non-Small Cell Lung Cancer"],"prefix":"10.3390","volume":"14","author":[{"given":"Sophie","family":"Seier","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Central Institute for Translational Cancer Research Technische Universit\u00e4t M\u00fcnchen (TranslaTUM), Klinikum Rechts der Isar, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bashiri Dezfouli","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Central Institute for Translational Cancer Research Technische Universit\u00e4t M\u00fcnchen (TranslaTUM), Klinikum Rechts der Isar, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lennartz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Central Institute for Translational Cancer Research Technische Universit\u00e4t M\u00fcnchen (TranslaTUM), Klinikum Rechts der Isar, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-6431","authenticated-orcid":false,"given":"Alan Graham","family":"Pockley","sequence":"additional","affiliation":[{"name":"John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK"},{"name":"multimmune GmbH, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Klein","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Klinikum Rechts der Isar, TUM, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2616-3137","authenticated-orcid":false,"given":"Gabriele","family":"Multhoff","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Central Institute for Translational Cancer Research Technische Universit\u00e4t M\u00fcnchen (TranslaTUM), Klinikum Rechts der Isar, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"190024","DOI":"10.1183\/16000617.0024-2019","article-title":"Interdisciplinary multimodality management of stage III nonsmall cell lung cancer","volume":"28","author":"Huber","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2015.02.048","article-title":"A Validated Prediction Model for Overall Survival from Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients","volume":"92","author":"Oberije","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_5","first-page":"1015","article-title":"Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study","volume":"21","author":"Malusecka","year":"2001","journal-title":"Anticancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1440-1746.2003.03011.x","article-title":"Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer","volume":"18","author":"Hwang","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3816\/CGC.2004.n.013","article-title":"Plasma levels of heat shock protein 70 in patients with prostate cancer: A potential biomarker for prostate cancer","volume":"3","author":"Abe","year":"2004","journal-title":"Clin. Prostate Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"669366","DOI":"10.3389\/fmolb.2021.669366","article-title":"Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients","volume":"8","author":"Lobinger","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-030-48238-1_27","article-title":"The Warburg Effect: Historical Dogma Versus Current Rationale","volume":"1269","author":"Vaupel","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ijc.2910610222","article-title":"A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells","volume":"61","author":"Multhoff","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13014-015-0461-1","article-title":"Role of membrane Hsp70 in radiation sensitivity of tumor cells","volume":"10","author":"Murakami","year":"2015","journal-title":"Radiat. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2015.02.013","article-title":"The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation","volume":"368","author":"Multhoff","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<942::AID-IJC25>3.0.CO;2-1","article-title":"Differential Hsp70 plasma-membrane expression on primary human tumors and metastases in mice with severe combined immunodeficiency","volume":"77","author":"Botzler","year":"1998","journal-title":"Int. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.cdd.4401510","article-title":"Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: Protection against radiation-induced effects and target structure for natural killer cells","volume":"12","author":"Gehrmann","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"883694","DOI":"10.3389\/fimmu.2022.883694","article-title":"CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells","volume":"13","author":"Yazdi","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1158\/1078-0432.CCR-03-0683","article-title":"Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: A clinical phase i trial","volume":"10","author":"Krause","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fimmu.2015.00162","article-title":"Heat shock protein 70 (Hsp70) peptide activated natural killer (NK) cells for the treatment of patients with non-small Cell lung cancer (NSCLC) after radiochemotherapy (RCTx)\u2014From preclinical studies to a clinical Phase II trial","volume":"6","author":"Specht","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"41173","DOI":"10.1074\/jbc.M302644200","article-title":"Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B","volume":"278","author":"Gross","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","article-title":"Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells","volume":"65","author":"Gastpar","year":"2005","journal-title":"Cancer Res."},{"key":"ref_20","first-page":"4","article-title":"Quantitative analysis of liposomal heat shock protein 70 in the blood of tumor patients using a novel lipHsp70 ELISA","volume":"5","author":"Breuninger","year":"2015","journal-title":"J. Clin. Cell. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Werner, C., Stangl, S., Salvermoser, L., Schwab, M., Shevtsov, M., Xanthopoulos, A., Wang, F., Dezfouli, A.B., Tholke, D., and Ostheimer, C. (2021). Hsp70 in Liquid Biopsies-A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer. Cancers, 13.","DOI":"10.3390\/cancers13153706"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ijrobp.2013.11.008","article-title":"Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models","volume":"88","author":"Bayer","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fimmu.2015.00556","article-title":"Correlation of Hsp70 serum levels with gross tumor volume and composition of lymphocyte subpopulations in patients with squamous cell and adeno non-small cell lung cancer","volume":"6","author":"Gunther","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-20-1141","article-title":"Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial","volume":"26","author":"Multhoff","year":"2020","journal-title":"Clin. Cancer. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/3-540-29717-0_12","article-title":"Heat shock proteins in immunity","volume":"Volume 172","author":"Huebert","year":"2006","journal-title":"Handbook of Experimental Pharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00066-019-01434-9","article-title":"Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: A case study","volume":"195","author":"Kokowski","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1073\/pnas.1016065108","article-title":"Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody","volume":"108","author":"Stangl","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cca.2012.03.008","article-title":"Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: A multi-institutional case-control study","volume":"413","author":"Zimmermann","year":"2012","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bashiri Dezfouli, A., Yazdi, M., Pockley, A.G., Khosravi, M., Kobold, S., Wagner, E., and Multhoff, G. (2021). NK cells armed with chimeric antigen receptors (CAR): Roadblocks to successful development. Cells, 10.","DOI":"10.3390\/cells10123390"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"896228","DOI":"10.3389\/fimmu.2022.896228","article-title":"All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity","volume":"13","author":"Pesini","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1379\/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2","article-title":"A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity","volume":"6","author":"Multhoff","year":"2001","journal-title":"Cell Stress. Chaperones."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1379\/1466-1268(2003)008<0348:HSPRIA>2.0.CO;2","article-title":"Heat shock protein 70-reactivity is associated with increased cell surface density of CD94\/CD56 on primary natural killer cells","volume":"8","author":"Gross","year":"2003","journal-title":"Cell Stress Chaperones"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/intimm\/dxac024","article-title":"The cellular and molecular basis of CD69 function in anti-tumor immunity","volume":"34","author":"Wang","year":"2022","journal-title":"Int. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-065X.2006.00445.x","article-title":"The role of regulatory T cells in the control of natural killer cells: Relevance during tumor progression","volume":"214","author":"Ghiringhelli","year":"2006","journal-title":"Immunol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1158\/1078-0432.CCR-21-0206","article-title":"CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?","volume":"27","author":"Miggelbrink","year":"2021","journal-title":"Clin. Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/22\/5701\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:22:31Z","timestamp":1760145751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/22\/5701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":36,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["cancers14225701"],"URL":"https:\/\/doi.org\/10.3390\/cancers14225701","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]}}}